Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic targets in pancreatic cancer
- DOI
- 10.1038/s41467-026-73871-x
- Published
- 2026-05-30
- Container
- Nature Communications
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-026-73871-x,
title = {Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic targets in pancreatic cancer},
author = {Feng Chen and Xiaoying Lou and Xingting Guo and Ye Guo and Yuan Huang and Kexin Li and Yan Song and Jiangtao Li and Jing Wang and Kai Lin and Ruijun Tian and Min Wang and Xudong Dai and Hezhi Fang and Wei Cui},
year = {2026},
journal = {Nature Communications},
doi = {10.1038/s41467-026-73871-x},
url = {https://doi.org/10.1038/s41467-026-73871-x}
}RIS
TY - JOUR TI - Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic targets in pancreatic cancer AU - Feng Chen AU - Xiaoying Lou AU - Xingting Guo AU - Ye Guo AU - Yuan Huang AU - Kexin Li AU - Yan Song AU - Jiangtao Li AU - Jing Wang AU - Kai Lin AU - Ruijun Tian AU - Min Wang AU - Xudong Dai AU - Hezhi Fang AU - Wei Cui PY - 2026 JO - Nature Communications DO - 10.1038/s41467-026-73871-x UR - https://doi.org/10.1038/s41467-026-73871-x ER -
APA
Chen, F., Lou, X., Guo, X., Guo, Y., Huang, Y., Li, K., Song, Y., Li, J., Wang, J., Lin, K., Tian, R., Wang, M., Dai, X., Fang, H., & Cui, W. (2026). Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic targets in pancreatic cancer. Nature Communications. https://doi.org/10.1038/s41467-026-73871-x
Source records
- crossref · retrieved 2026-09-26T18:53:42.822Z